By Julia Goodman ( October 31, 2017, 9:47 PM EDT) -- Valeant Pharmaceuticals International Inc. will pay $13 million to biotechnology company PDL BioPharma Inc. to settle a lawsuit alleging that Valeant owes more than $20 million in unpaid royalties for sales of diabetes drug Glumetza, PDL BioPharma said Monday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.